Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4

IRCCS Policlinico S. Matteo

Status: Unknown

Conditions: Diabetes; Insulin Resistance; End Stage Renal Disease

Study type: Observational

Funder types: Other

Identifiers

NCT00910130

RBP4

Details and patient eligibility

About

The purpose of this study is to determine whether Retinol binding protein 4 has a role in insulin resistance development in patients suffering from end stage renal disease on hemodialysis.

Enrollment: 30 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Hemodialysis for "End Stage Renal Disease group"
• Normal Renal Function for "Control group"

Exclusion criteria

• Diabetes
• Malnutrition
• Malignancy
• Acute Infection
• Chronic Active Infection

Trial design

30 participants in 2 patient groups

End Stage Renal Disease

Description:

Patients suffering from End Stage Renal Disease on Hemodialysis, without Diabetes

Control

Description:

Healthy people, with normal Renal Function and without Diabetes, matched with "ESRD group" for age, gender, BMI